Skip to main content
Apheris

Forward-Deployed Scientist – Computational & Medicinal Chemistry

RemoteGermany only
Published
Role
Research
Employment
Full-time
Company size
Startup
Salary not disclosed
Check eligibility

Open to DE only. Set where you work from to check your eligibility.

No BS summary

Structure-based drug discovery expert needed to drive adoption of the Co-Folding Application in pharma R&D. You will be a power user, working with computational and medicinal chemists to test, benchmark, and apply models to real programs. Requires PhD in computational/medicinal chemistry and hands-on experience with structure-based workflows.

Core skills

structure-based drug discoveryCo-Folding Application

Required skills

computational chemistrymedicinal chemistrystructure-based workflowsco-foldingdockingprotein–ligand modelingmolecular visualizationcheminformatics toolsscripting

Optional skills

customer-facing roleCROapplication scientistOpenFoldBoltzstructure/affinity prediction toolsenterprise IT/data environmentslarge pharma

What you'll do

  • Act as a forward-deployed scientist, focused on driving adoption and real, measurable impact
  • Work hands-on with pharma users of the Co-Folding Application, guiding benchmarking, testing, and application to real discovery programs
  • Build relationships with the relevant stakeholders across pharma R&D, from computational and medicinal chemists to program leaders
  • Feed insights from the field back to Product and the AI Applications Team to shape platform improvements
  • Run in-person and remote workshops to train users and share best practices with research teams
  • Develop case studies that demonstrate impact and can be replicated across projects
  • Contribute scientific content such as example datasets, usage guidelines, and evaluation protocols

What they require

  • PhD in computational chemistry, medicinal chemistry, or a related field
  • Hands-on experience as a power user in structure-based workflows - co-folding, docking, protein–ligand modeling in real drug discovery programs
  • Familiarity with molecular visualization and cheminformatics tools (e.g., PyMOL, RDKit)
  • Credibility with both computational and medicinal chemists, and ability to bridge what each group needs
  • Basic scripting skills to run and explain notebooks and analyses
  • Comfortable working without full specifications - takes ownership, makes progress under ambiguity
  • Communicates clearly across technical and non-technical audiences

Benefits

  • Industry-competitive compensation, including early-stage virtual share options
  • Remote-first working – work where you work best, whether from home or a co-working space near you
  • Great suite of benefits, including a wellbeing budget, mental health benefits, a work-from-home budget, a co-working stipend and a learning and development budget
  • Regular team lunches and social events
  • Generous holiday allowance
  • Office Days at our Berlin HQ or a different European location (3x a year)
  • A fun, diverse team of mission-driven individuals with a drive to see AI and ML used for good
  • Plenty of room to grow personally and professionally and shape your own role

At Apheris, we are building the future of how AI is applied in pharmaceutical R&D. We enable leading pharmaceutical teams to discover and develop drugs faster. We host the industry’s largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability. Across these networks, models are trained on proprietary industry datasets to achieve higher performance and broader applicability while keeping data control and IP protected. We deliver these superior models through drug discovery applications that enable teams to run them at scale, further customize them, and integrate them into existing R&D workflows. AI Structural Biology (AISB) Network: Pharmaceutical companies collaborate in the field of co-folding, structure-based binding affinity predictions and antibody design.ADMET Network: Pharmaceutical and biotech companies collaborate to improve small-molecule property prediction and expand into further drug modalities.Antibody developability Network:Pharma partners collaborate to federate historical and purpose-built antibody developability data sets for secure ML training, without data leaving each partner’s environment.

BiotechStartupapheris.com/
Salary not disclosed